A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
for Chronic Lymphocytic Leukemia (CLL)
Sites in Salt Lake City +6 more locations
Sponsor: Nurix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT04830137·Phase 1·Recruiting·Listed Apr 2021